December 10, 2015

With FDA approved new Immunotherapy Drugs for Myeloma, are Auto and Allo Transplants on the Way Out?

In just the past 2 months, 3 new drugs for myeloma treatment have been approved by the FDA. With so many more options for immunotherapy drugs coming up, will transplants continue to be an integral part of myeloma treatment? Tune in December 15th at 10 am ET to listen to myeloma advocates and survivors discuss…

November 18, 2015

Handling the Holidays Event on December 3

The Myeloma Institute Social Work  Department will host a Patient Support Seminar entitled “Handling the Holidays – a gift of healthy tips” on Thursday, December 3  from 5:30 – 7:00 PM.   The seminar will be held in the Betsy Blass Boardroom on the 10th floor of the Cancer Institute and refreshments will be provided.

November 17, 2015

FDA approves Darzalex for patients with previously treated multiple myeloma

Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma. Read more here:  

October 15, 2015

Guess the Diagnosis with Frits van Rhee, MD, PhD

Guess the Diagnosis: Case 1 Watch the video segments Case-Based Peer Perspectives on Targeted Oncology  Lisa B. is a 47-year-old female store owner from St. Louis, with a 10-month history of fatigue, night sweats, and weight loss. She presents to her PCP with generalized lymphadenopathy, most prominent in the cervical region; there is no polyneuropathy,…

October 6, 2015

Gareth John Morgan

“Gareth Morgan is a true world leader in the field of myeloma research.” Read more about Myeloma Institute Director, Dr. Gareth Morgan, in yesterday’s high profile section in the Arkansas Democrat-Gazette newspaper.  

September 18, 2015

How I Treat Myeloma Using Genomic Analysis

Dr. Faith Davies is a professor of medicine and the director of the Phase I Clinical Trials program for both the Myeloma Institute and the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences. She is recognized internationally for her focus on innovative targeted molecular therapies and her expertise in the…

September 14, 2015

Understanding Your Multiple Myeloma Genetics and Why You Need to Know

Originally from the UK but now at UAMS, Dr. Gareth Morgan, MD, PhD believes it to be a very valuable test and uses the information that the test provides to alter treatment approaches. He notes: We did significant work comparing the GEP70 to i-FISH, the interface FISH which people out there use as a standard…

August 26, 2015

Genetic Mutation Analysis May Improve Treatment in Multiple Myeloma

Gareth Morgan, M.D., FRCP, FRCPath, Ph.D.

Testing for genetic risk factors may improve myeloma treatments by identifying those at risk for more aggressive disease. This study, published in the Journal of Clinicial Oncology and led by researchers in London, including our own Myeloma Institute Director, Dr. Gareth Morgan, is the first to link genetic mutations in myeloma cells to the chances…

August 14, 2015

My Advice to Myeloma Patients

August 13, 2015

New publication

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

Previous page Next page